Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Profusa Stock

Q: How to sell Profusa stock?

If you hold private company shares of Profusa - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Profusa stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

profusa.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $60.95MM

Profusa is a developer of real-time biosensors designed to provide unprecedented insights into our overall health status.

Buy or sell Profusa stockLearn more about Profusa IPO

OverviewFinancingsValuation

Enterprise Value

Access Profusa’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Profusa.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

William McMillan

Co-Founder, President and Chief Scientific Officer

Bruce Smith

Chief of Staff

Natalie Wisniewski Ph.D

Co-Founder, Board Member & Chief Technology Officer

Soya Gamsey Ph.D

Vice President, Chemistry Development

Kerstin Rebrin

Vice President, Medical Affairs & Clinical Development

Ben Hwang Ph.D

Chairman & Chief Executive Officer

Bradley Rice Ph.D

Vice President, Engineering R&D

Board Members

Karen Liu Ph.D

3E Bioventures Capital

Tom Gutshall

CampVentures

Ben Hwang Ph.D

William Frist MD

Joan Braddi

Profusa stock FAQs

Can you buy Profusa stock?

As Profusa is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Profusa, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Profusa stock?

To invest in a private company like Profusa through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Profusa stock?

Yes, you may be able to sell your Profusa stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Profusa stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Profusa stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Profusa a public company?

No, Profusa is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Profusa’s stock price?

Profusa is a privately held company and therefore does not have a public stock price. However, you may access Profusa’s private market stock price with Forge Data.

What is Profusa’s stock ticker symbol?

Profusa does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Legal Desire 12/01/2023

Sidley Represents Profusa, Inc. in Merger with SPAC NorthView Acquisition Corp.

Profusa, a digital health company, is set to merge with NorthView Acquisition Corp, a publicly traded special purpose acquisition company (SPAC), as per a definitive business combination agreement. The merger will see Profusa become a publicly listed company. Profusa's technology allows for the constant transmission of wireless and cloud-based medical grade data for individual, professional and medical use.

TechCrunch 07/17/2023

Herself Health, providing primary care to women 65 and over, raises $26M

Herself Health, a healthcare provider focused on women aged 65 and over, has raised $26 million in a series A funding round led by Michael Cline of Accretive. The company, founded by Kristen Helton formerly of Amazon Care, operates a clinic in St. Paul, Minnesota where it offers a holistic approach to care. Herself Health plans to use the funding to expand its services and open more clinics.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.